Mindray Announces Two Senior Promotions and New Hire

SHENZHEN, China, Sept. 25 /Xinhua-PRNewswire/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced the promotion of two senior executives, Minghe Cheng and Jie Liu, and the appointment of Patrick Ma as assistant vice president of finance.

"We are pleased to expand our executive team," said Xu Hang, Mindray's chairman and co-chief executive officer. "Mr. Cheng and Mr. Jie have contributed significantly to both our domestic and international growth and I am confident they will continue to excel in their increased leadership roles. Mr. Ma's background in global financial management will be a strong addition to our team as we continue to experience rapid growth."

Minghe Cheng, co-founder of Mindray, will serve as executive vice president of strategic development. Mr. Cheng brings more than 20 years of experience in medical device research and development, manufacturing, sales and marketing. He previously served as Mindray's executive vice president of sales and marketing since 2004 and vice president of sales and marketing from 2000 to 2003. Mr. Cheng received both his master's and bachelor's degrees in biomedical engineering from Shanghai Jiaotong University.

"The executive vice president of strategic development position gives Mindray an important tool to implement our strategy for sustainable, high growth over the long-term," said Mr. Li Xiting, Mindray's president and

co-chief executive officer. "In his new role, Mr. Cheng will focus on business development activities as well as building the Mindray brand in international markets. As part of this responsibility, Mr. Cheng will leverage our team of over one thousand research and development engineers to tailor Mindray products optimally for users in various markets around the world."

Jie Liu will serve as executive vice president of international sales and marketing. Previously, Mr. Liu was Mindray's vice president of international sales and marketing. Prior to joining Mindray, Mr. Liu gained extensive experience in sales, marketing and product management with multinational companies such as Hewlett-Packard and Johnson and Johnson. He holds an MBA from the University of Michigan, a Master of Science from the Hefei Branch of the Chinese Academy of Sciences and a bachelor's degree in optical instrumentation from the College of Information Science and Engineering at Zhejiang University.

Mindray has appointed Patrick Ma as assistant vice president of finance, effective September 17, 2007. Reporting to Ms. Joyce Hsu, Mindray's chief financial officer, Mr. Ma will be responsible for overseeing financial reporting and accounting activities for the company. Mr. Ma was previously regional financial controller for Fresenius Medical Care, a leading NYSE- and Frankfurt-listed European healthcare company. Mr. Ma holds a bachelor's degree in business administration from the City University of Hong Kong and is a fellow of the Association of Certified Public Accountants.

About Mindray

Mindray Medical International Limited is a leading developer, manufacturer and marketer of medical devices in China with a significant and growing presence worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems. Mindray is headquartered in Shenzhen, China, and has 29 local sales and service offices in China, as well as sales and service offices in Boston, Istanbul, London, Mumbai, Seattle and Vancouver. For more information, please visit http://www.mindray.com .

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Statements that are not historical facts, including statements about Mindray's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Information regarding these risks and uncertainties is included in our public filings with the Securities and Exchange Commission. All information provided in this press release is as of September 25, 2007, and Mindray undertakes no duty to update such information, except as required under applicable law.

For investor and media inquiries please contact:

In China:

Investor Relations

Mindray Medical International Limited

Tel: +86-755-2658-2518

Email: IR@Mindray.com

Justin Knapp

Ogilvy Public Relations Worldwide, Beijing

Tel: +86-10-8520-6556

Email: Justin.Knapp@Ogilvy.com

In the United States:

Jeremy Bridgman

Ogilvy Public Relations Worldwide, New York

Tel: +1-212-880-5363